Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Wiewrodt

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Free Radical Biology & Medicine|April 10, 2003
PECAM-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxideThomas D Sweitzer, Anu P Thomas, Rainer Wiewrodt, et al.
Journal of Neuro-Oncology|April 24, 2024
Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness statusJohanna Jost, Klaus Völker, Ralf Brandt, et al.
Journal of Neuro-Oncology|April 1, 2024
Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness statusJohanna Jost, Klaus Völker, Ralf Brandt, et al.
Anticancer Research|April 1, 2009
Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissueLars Henning Schmidt, Stefan Biesterfeld, Andreas Kümmel, et al.
Journal of Neuro-Oncology|June 12, 2023
Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experienceJohanna Jost, Michael Müther, Ralf Brandt, et al.
Clinical & Developmental Immunology|March 5, 2008
Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary diseaseMarkus P Radsak, Christian Taube, Philipp Haselmayer, et al.
Scientific Reports|July 19, 2018
Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancerAndreas Kuemmel, Astrid Alflen, Lars Henning Schmidt, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
c-kit expression in adenocarcinomas of the lungPatrick Micke, Jan Georg Hengstler, Heidi Albrecht, et al.
Oncotarget|September 1, 2018
Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patientsMarion Rapp, Stephanie Schipmann, Kira Hoffmann, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 9, 2008
The prognostic impact of blood group-related antigen Lewis Y and the ABH blood groups in resected non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Free Radical Biology & Medicine|April 10, 2003
PECAM-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxideThomas D Sweitzer, Anu P Thomas, Rainer Wiewrodt, et al.
Journal of Neuro-Oncology|April 24, 2024
Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness statusJohanna Jost, Klaus Völker, Ralf Brandt, et al.
Journal of Neuro-Oncology|April 1, 2024
Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness statusJohanna Jost, Klaus Völker, Ralf Brandt, et al.
Anticancer Research|April 1, 2009
Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissueLars Henning Schmidt, Stefan Biesterfeld, Andreas Kümmel, et al.
Journal of Neuro-Oncology|June 12, 2023
Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experienceJohanna Jost, Michael Müther, Ralf Brandt, et al.
Clinical & Developmental Immunology|March 5, 2008
Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary diseaseMarkus P Radsak, Christian Taube, Philipp Haselmayer, et al.
Scientific Reports|July 19, 2018
Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancerAndreas Kuemmel, Astrid Alflen, Lars Henning Schmidt, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
c-kit expression in adenocarcinomas of the lungPatrick Micke, Jan Georg Hengstler, Heidi Albrecht, et al.
Oncotarget|September 1, 2018
Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patientsMarion Rapp, Stephanie Schipmann, Kira Hoffmann, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 9, 2008
The prognostic impact of blood group-related antigen Lewis Y and the ABH blood groups in resected non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Pageof 7